(Hypertension. 1995;25:918-923.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Medicine and Therapeutics, University of Aberdeen (Scotland) (N.B.); the Clinical Pharmacology Unit, Department of Pharmacology and Clinical Pharmacology, St George's Hospital Medical School, London (A.C., J.C., B.R., P.V.); and the Department of Medicine, Western General Hospital, University of Edinburgh (Scotland) (D.W.), UK.
Correspondence to Patrick Vallance, Clinical Pharmacology Unit, Department of Pharmacology and Clinical Pharmacology, St George's Hospital Medical School, London SW17 0RE, UK.
Abstract Venous occlusion plethysmography has been widely used to study forearm blood flow. The principle of the technique is straightforward: the rate of swelling of the forearm during occlusion of venous return is used to assess the rate of arterial inflow. Provided that perfusion pressure (arterial blood pressure) remains constant, changes in flow reflect changes in smooth muscle tone in small arteries and arterioles. Local infusion into the brachial artery allows assessment of the direct effect of drugs on vascular tone and has been used to probe the roles of endogenous mediators. The technique is at its most powerful when dose-response relationships to different drugs or mediators within a single study are being compared but can also be used for comparison of responses to drugs between healthy control subjects and patient populations. However, when responses between groups are being compared, it is important to take into account the starting conditions of baseline blood flow and pressure. This article describes venous occlusion plethysmography, discusses the presentation and analysis of data (dose of drug or concentration? forearm blood flow or resistance?), and highlights certain potential problems and limitations of the technique as a means of studying disease states.
Key Words: blood flow plethysmography vascular resistance
This article has been cited by other articles:
![]() |
M. Bosselaar, H. Boon, L. J. C. van Loon, P. H. H. van den Broek, P. Smits, and C. J. Tack Intra-arterial AICA-riboside administration induces NO-dependent vasodilation in vivo in human skeletal muscle Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E759 - E766. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lucchinetti, J. Wacker, C. Maurer, M. Keel, L. Harter, K. Zaugg, and M. Zaugg Helium Breathing Provides Modest Antiinflammatory, but No Endothelial Protection Against Ischemia-Reperfusion Injury in Humans In Vivo Anesth. Analg., July 1, 2009; 109(1): 101 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Cosentino, D Hurlimann, C Delli Gatti, R Chenevard, N Blau, N J Alp, K M Channon, M Eto, P Lerch, F Enseleit, et al. Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia Heart, April 1, 2008; 94(4): 487 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mittermayer, G. Schaller, J. Pleiner, K. Krzyzanowska, S. Kapiotis, M. Roden, and M. Wolzt Rosiglitazone Prevents Free Fatty Acid-Induced Vascular Endothelial Dysfunction J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2574 - 2580. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Robinson, C. A. Ludlam, N. A. Boon, and D. E. Newby Endothelial Fibrinolytic Capacity Predicts Future Adverse Cardiovascular Events in Patients With Coronary Heart Disease Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1651 - 1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J Hamilton, G. T Chew, and G. F Watts Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 89 - 102. [Abstract] [PDF] |
||||
![]() |
J. George, E. Carr, J. Davies, J.J.F. Belch, and A. Struthers High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid Circulation, December 5, 2006; 114(23): 2508 - 2516. [Abstract] [Full Text] [PDF] |
||||
![]() |
C H Strey, J M Young, J H Lainchbury, C M Frampton, M G Nicholls, A M Richards, and R S Scott Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure Heart, November 1, 2006; 92(11): 1603 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Green, A. J. Maiorana, M. E. Tschakovsky, K. E. Pyke, C. J. Weisbrod, and G. O'Driscoll Relationship between changes in brachial artery flow-mediated dilation and basal release of nitric oxide in subjects with Type 2 diabetes Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1193 - H1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M.A.C. Martens, T. J. Rabelink, J. op 't Roodt, E. J.P. de Koning, and F. L.J. Visseren TNF-{alpha} induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-{gamma} agonist pioglitazone Eur. Heart J., July 1, 2006; 27(13): 1605 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Henry, D. E. Newby, D. J. Webb, P. W. F. Hadoke, and C. J. O'Brien Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2528 - 2532. [Abstract] [Full Text] [PDF] |
||||
![]() |
J W Ferguson, A R Dover, S Chia, N L M Cruden, P C Hayes, and D E Newby Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites Gut, April 1, 2006; 55(4): 542 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
S D Robinson, C A Ludlam, N A Boon, and D E Newby Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease Heart, February 1, 2006; 92(2): 170 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hesse, H. Siedler, S. P. Luntz, B. M. Arendt, R. Goerlich, R. Fricker, M. Heer, and W. E. Haefeli Modulation of endothelial and smooth muscle function by bed rest and hypoenergetic, low-fat nutrition J Appl Physiol, December 1, 2005; 99(6): 2196 - 2203. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Ebert, D. J. Ficke, S. R. Arain, M. N. Holtz, and H. Shankar Vasodilation from Sufentanil in Humans Anesth. Analg., December 1, 2005; 101(6): 1677 - 1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mittermayer, J. Pleiner, G. Schaller, S. Zorn, K. Namiranian, S. Kapiotis, G. Bartel, M. Wolfrum, M. Brugel, J. Thiery, et al. Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1752 - H1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Berger, C. Hesse, C. Dehnert, H. Siedler, P. Kleinbongard, H. J. Bardenheuer, M. Kelm, P. Bartsch, and W. E. Haefeli Hypoxia Impairs Systemic Endothelial Function in Individuals Prone to High-Altitude Pulmonary Edema Am. J. Respir. Crit. Care Med., September 15, 2005; 172(6): 763 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mittermayer, G. Schaller, J. Pleiner, A. Vychytil, G. Sunder-Plassmann, W. H. Horl, and M. Wolzt Asymmetrical Dimethylarginine Plasma Concentrations Are Related to Basal Nitric Oxide Release but Not Endothelium-Dependent Vasodilation of Resistance Arteries in Peritoneal Dialysis Patients J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1832 - 1838. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Passauer, F. Pistrosch, E. Bussemaker, G. Lassig, K. Herbrig, and P. Gross Reduced Agonist-Induced Endothelium-Dependent Vasodilation in Uremia Is Attributable to an Impairment of Vascular Nitric Oxide J. Am. Soc. Nephrol., April 1, 2005; 16(4): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pleiner, G. Schaller, F. Mittermayer, S. Zorn, C. Marsik, S. Polterauer, S. Kapiotis, and M. Wolzt Simvastatin Prevents Vascular Hyporeactivity During Inflammation Circulation, November 23, 2004; 110(21): 3349 - 3354. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J Green, A. Maiorana, G. O'Driscoll, and R. Taylor Effect of exercise training on endothelium-derived nitric oxide function in humans J. Physiol., November 15, 2004; 561(1): 1 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.W. Broadhead, R.K. Kharbanda, M.J. Peters, and R.J. MacAllister KATP Channel Activation Induces Ischemic Preconditioning of the Endothelium in Humans In Vivo Circulation, October 12, 2004; 110(15): 2077 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Clapp, A. D. Hingorani, R. K. Kharbanda, V. Mohamed-Ali, J. W. Stephens, P. Vallance, and R. J. MacAllister Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress Cardiovasc Res, October 1, 2004; 64(1): 172 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Gornik and M. A. Creager Arginine and Endothelial and Vascular Health J. Nutr., October 1, 2004; 134(10): 2880S - 2887S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Green, J. H. Walsh, A. Maiorana, V. Burke, R. R. Taylor, and J. G. O'Driscoll Comparison of resistance and conduit vessel nitric oxide-mediated vascular function in vivo: effects of exercise training J Appl Physiol, August 1, 2004; 97(2): 749 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Macdonald, N Kennedy, and A D Struthers Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment Heart, July 1, 2004; 90(7): 765 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Sim, C. Farquharson, and A. D Struthers Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man Journal of Renin-Angiotensin-Aldosterone System, June 1, 2004; 5(2): 84 - 88. [Abstract] [PDF] |
||||
![]() |
S. J. Leslie, T. Attina, E. Hultsch, L. Bolscher, M. Grossman, M. A. Denvir, and D. J. Webb Comparison of two plethysmography systems in assessment of forearm blood flow J Appl Physiol, May 1, 2004; 96(5): 1794 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmitt, P. Gunaruwan, N. Payne, J. Taylor, L. Lee, A. J.M. Broadley, A. K. Nightingale, J. R. Cockcroft, A. D. Struthers, J. V. Tyberg, et al. Effects of Exogenous and Endogenous Natriuretic Peptides on Forearm Vascular Function in Chronic Heart Failure Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 911 - 917. [Abstract] [Full Text] |
||||
![]() |
I. M. Steiner, H. Langenberger, C. Marsik, B. X. Mayer, M. Fischer, A. Georgopoulos, M. Muller, G. Heinz, and C. Joukhadar Effect of norepinephrine on cefpirome tissue concentrations in healthy subjects J. Antimicrob. Chemother., March 1, 2004; 53(3): 506 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Helmy Responses to endothelin-1 in patients with advanced cirrhosis before and after liver transplantation Gut, March 1, 2004; 53(3): 470 - 471. [Full Text] [PDF] |
||||
![]() |
M. Schmitt, P. Gunaruwan, and M. P. Frenneaux Letters to the Editor: Rapid Nongenomic Aldosterone Effects in the Human Forearm? Hypertension, January 1, 2004; e1(1): . [Full Text] [PDF] |
||||
![]() |
D. J. Green, J. H. Walsh, A. Maiorana, M. J. Best, R. R. Taylor, and J. G. O'Driscoll Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2679 - H2687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pleiner, F. Mittermayer, G. Schaller, C. Marsik, R. J. MacAllister, and M. Wolzt Inflammation-induced vasoconstrictorhyporeactivity is caused by oxidative stress J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1656 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Walsh, G. Yong, C. Cheetham, G. F. Watts, G. J. O'Driscoll, R. R. Taylor, and D. J. Green Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects Eur. Heart J., September 2, 2003; 24(18): 1681 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ihlemann, C. Rask-Madsen, A. Perner, H. Dominguez, T. Hermann, L. Kober, and C. Torp-Pedersen Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H875 - H882. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Noseir, D. J. Ficke, A. Kundu, S. R. Arain, and T. J. Ebert Sympathetic and Vascular Consequences from Remifentanil in Humans Anesth. Analg., June 1, 2003; 96(6): 1645 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Helmy, D E Newby, R Jalan, P C Hayes, and D J Webb Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide Gut, March 1, 2003; 52(3): 410 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Robin, R. Kharbanda, P. Mclean, R. Campbell, and P. Vallance Protease-Activated Receptor 2-Mediated Vasodilatation in Humans In Vivo: Role of Nitric Oxide and Prostanoids Circulation, February 25, 2003; 107(7): 954 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Browne, D. Meeking, K. Shaw, and M. Cummings Review: Endothelial dysfunction and pre-symptomatic atherosclerosis in type 1 diabetes -- pathogenesis and identification The British Journal of Diabetes & Vascular Disease, January 1, 2003; 3(1): 27 - 34. [Abstract] [PDF] |
||||
![]() |
M. Annuk, B. Fellstrom, and L. Lind Cyclooxygenase inhibition improves endothelium-dependent vasodilatation in patients with chronic renal failure Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2159 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schalcher, K. Schad, H. P. Brunner-La Rocca, R. Schindler, E. Oechslin, C. Scharf, G. Suetsch, O. Bertel, and W. Kiowski Interaction of Sildenafil With cAMP-Mediated Vasodilation In Vivo Hypertension, November 1, 2002; 40(5): 763 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pleiner, F. Mittermayer, G. Schaller, R. J. MacAllister, and M. Wolzt High Doses of Vitamin C Reverse Escherichia coli Endotoxin-Induced Hyporeactivity to Acetylcholine in the Human Forearm Circulation, September 17, 2002; 106(12): 1460 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Goddard, D. J. Webb, P. Martin, and H. Krum Endothelin Antagonists and Hypertension: A Question of Dose? * Response Hypertension, September 1, 2002; e2(3): . [Full Text] [PDF] |
||||
![]() |
C. A.J. Farquharson, R. Butler, A. Hill, J. J.F. Belch, and A. D. Struthers Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure Circulation, July 9, 2002; 106(2): 221 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Green, C. Cheetham, C. Reed, L. Dembo, and G. O'Driscoll Assessment of brachial artery blood flow across the cardiac cycle: retrograde flows during cycle ergometry J Appl Physiol, July 1, 2002; 93(1): 361 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Irving, M. N. Carson, D. J. Webb, and B. R. Walker Peripheral Vascular Structure and Function in Men with Contrasting GH Levels J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3309 - 3314. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Kharbanda, B. Walton, M. Allen, N. Klein, A. D. Hingorani, R. J. MacAllister, and P. Vallance Prevention of Inflammation-Induced Endothelial Dysfunction: A Novel Vasculo-Protective Action of Aspirin Circulation, June 4, 2002; 105(22): 2600 - 2604. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. van Etten, E. J.P. de Koning, M. L. Honing, E. S. Stroes, C. A. Gaillard, and T. J. Rabelink Intensive Lipid Lowering by Statin Therapy Does Not Improve Vasoreactivity in Patients With Type 2 Diabetes Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): 799 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Arain, D. J. Williams, B. J. Robinson, T. D. Uhrich, and T. J. Ebert Vascular Responsiveness to Brachial Artery Infusions of Phenylephrine During Isoflurane and Desflurane Anesthesia Anesth. Analg., May 1, 2002; 94(5): 1137 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dawes, C. Sieniawska, T. Delves, R. Dwivedi, P. J. Chowienczyk, and J. M. Ritter Barium Reduces Resting Blood Flow and Inhibits Potassium-Induced Vasodilation in the Human Forearm Circulation, March 19, 2002; 105(11): 1323 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. J. Farquharson and A. D. Struthers Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure J. Am. Coll. Cardiol., March 6, 2002; 39(5): 767 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Phoon and L. G. Howes Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT2- receptors Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1): 36 - 39. [Abstract] [PDF] |
||||
![]() |
C. Buckley, P. W F Hadoke, E. Henry, and C. O'Brien Systemic vascular endothelial cell dysfunction in normal pressure glaucoma Br J Ophthalmol, February 1, 2002; 86(2): 227 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B Wilkinson, J. T Affolter, S. L de Haas, M Paola Pellegrini, J. Boyd, M. J Winter, R. J Balment, and D. J Webb High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man Cardiovasc Res, February 1, 2002; 53(2): 341 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Annuk, M. Zilmer, L. Lind, T. Linde, and B. Fellstrom Oxidative Stress and Endothelial Function in Chronic Renal Failure J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2747 - 2752. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rask-Madsen, N. Ihlemann, T. Krarup, E. Christiansen, L. Kober, C. Nervil Kistorp, and C. Torp-Pedersen Insulin Therapy Improves Insulin-Stimulated Endothelial Function in Patients With Type 2 Diabetes and Ischemic Heart Disease Diabetes, November 1, 2001; 50(11): 2611 - 2618. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Clive, D. J. Webb, A. MacLellan, A. Young, B. Byrne, L. Robson, J. F. Smyth, and D. I. Jodrell Forearm Blood Flow and Local Responses to Peptide Vasodilators: A Novel Pharmacodynamic Measure in the Phase I Trial of Antagonist G, a Neuropeptide Growth Factor Antagonist Clin. Cancer Res., October 1, 2001; 7(10): 3071 - 3078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maiorana, G. O'Driscoll, C. Cheetham, L. Dembo, K. Stanton, C. Goodman, R. Taylor, and D. Green The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes J. Am. Coll. Cardiol., September 1, 2001; 38(3): 860 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Storey, C. J Perry, and J. R Petrie Review: Endothelial dysfunction in type 2 diabetes The British Journal of Diabetes & Vascular Disease, August 1, 2001; 1(1): 22 - 27. [Abstract] [PDF] |
||||
![]() |
N. Tzemos, P. O. Lim, and T. M. MacDonald Nebivolol Reverses Endothelial Dysfunction in Essential Hypertension: A Randomized, Double-Blind, Crossover Study Circulation, July 31, 2001; 104(5): 511 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. lannuzzi, G. Jannuzzo, C. Sapio, P. Pauciullo, D. Jorio, N. Spampinato, M. Mancini, and P. Rubba L-Arginine Improves Post-Ischemic Vasodilation in Coronary Heart Disease Patients Taking Vasodilating Drugs Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2001; 6(2): 121 - 127. [Abstract] [PDF] |
||||
![]() |
P. S. Jhund, N. Dawson, A. P. Davie, N. Sattar, J. Norrie, K. P. J. O'Kane, and J. J. V. McMurray Attenuation of endothelin-1 induced vasoconstriction by 17{beta} estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1367 - 1373. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. H. Honing, P. Smits, P. J. Morrison, J. C. Burnett Jr, and T. J. Rabelink C-Type Natriuretic Peptide-Induced Vasodilation Is Dependent On Hyperpolarization in Human Forearm Resistance Vessels Hypertension, April 1, 2001; 37(4): 1179 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Kharbanda, M. Peters, B. Walton, M. Kattenhorn, M. Mullen, N. Klein, P. Vallance, J. Deanfield, and R. MacAllister Ischemic Preconditioning Prevents Endothelial Injury and Systemic Neutrophil Activation During Ischemia-Reperfusion in Humans In Vivo Circulation, March 27, 2001; 103(12): 1624 - 1630. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Annuk, L. Lind, T. Linde, and B. Fellstrom Impaired endothelium-dependent vasodilatation in renal failure in humans Nephrol. Dial. Transplant., February 1, 2001; 16(2): 302 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bragulat, Alejandro de la Sierra, M. T. Antonio, and A. Coca Endothelial Dysfunction in Salt-Sensitive Essential Hypertension Hypertension, February 1, 2001; 37(2): 444 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Mather, E. G. Norman, J. C. Prior, and T. G. Elliott Preserved Forearm Endothelial Responses with Acute Exposure to Progesterone: A Randomized Cross-Over Trial of 17-{beta} Estradiol, Progesterone, and 17-{beta} Estradiol with Progesterone in Healthy Menopausal Women J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4644 - 4649. [Abstract] [Full Text] |
||||
![]() |
C. M. Stein, C. C. Lang, I. Singh, H. B. He, and A. J. J. Wood Increased Vascular Adrenergic Vasoconstriction and Decreased Vasodilation in Blacks : Additive Mechanisms Leading to Enhanced Vascular Reactivity Hypertension, December 1, 2000; 36(6): 945 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Christ, A. Bauer, D. Brugger, M. Niklas, I. B. Gartside, and J. Gamble Description and validation of a novel liquid metal-free device for venous congestion plethysmography J Appl Physiol, October 1, 2000; 89(4): 1577 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maiorana, G. O'Driscoll, L. Dembo, C. Cheetham, C. Goodman, R. Taylor, and D. Green Effect of aerobic and resistance exercise training on vascular function in heart failure Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1999 - H2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. PASSAUER, E. BÜSSEMAKER, U. RANGE, M. PLUG, and P. GROSS Evidence In Vivo Showing Increase of Baseline Nitric Oxide Generation and Impairment of Endothelium-Dependent Vasodilation in Normotensive Patients on Chronic Hemodialysis J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1726 - 1734. [Abstract] [Full Text] |
||||
![]() |
A. D. Hingorani, J. Cross, R. K. Kharbanda, M. J. Mullen, K. Bhagat, M. Taylor, A. E. Donald, M. Palacios, G. E. Griffin, J. E. Deanfield, et al. Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans Circulation, August 29, 2000; 102(9): 994 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fichtlscherer, G. Rosenberger, D. H. Walter, S. Breuer, S. Dimmeler, and A. M. Zeiher Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease Circulation, August 29, 2000; 102(9): 1000 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Preik, M. Kelm, P. Rosen, D. Tschope, and B. E. Strauer Additive Effect of Coexistent Type 2 Diabetes and Arterial Hypertension on Endothelial Dysfunction in Resistance Arteries of Human Forearm Vasculature Angiology, July 1, 2000; 51(7): 545 - 554. [Abstract] [PDF] |
||||
![]() |
M. P Love, C. J Ferro, W. G Haynes, C. Plumpton, A. P Davenport, D. J Webb, and J. J.V McMurray Endothelin receptor antagonism in patients with chronic heart failure Cardiovasc Res, July 1, 2000; 47(1): 166 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bayerle-Eder, M. Wolzt, E. Polska, H. Langenberger, J. Pleiner, D. Teherani, G. Rainer, K. Polak, H.-G. Eichler, and L. Schmetterer Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humans Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1667 - R1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. H. Honing, P. Smits, P. J. Morrison, and T. J. Rabelink Bradykinin-Induced Vasodilation of Human Forearm Resistance Vessels Is Primarily Mediated by Endothelium-Dependent Hyperpolarization Hypertension, June 1, 2000; 35(6): 1314 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ueda, S. Masumori-Maemoto, K. Ashino, T. Nagahara, E. Gotoh, S. Umemura, and M. Ishii Angiotensin-(1-7) Attenuates Vasoconstriction Evoked by Angiotensin II but Not by Noradrenaline in Man Hypertension, April 1, 2000; 35(4): 998 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Butler, A. D. Morris, J. J. F. Belch, A. Hill, and A. D. Struthers Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension Hypertension, March 1, 2000; 35(3): 746 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. J. Farquharson and A. D. Struthers Spironolactone Increases Nitric Oxide Bioactivity, Improves Endothelial Vasodilator Dysfunction, and Suppresses Vascular Angiotensin I/Angiotensin II Conversion in Patients With Chronic Heart Failure Circulation, February 15, 2000; 101(6): 594 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vigili de Kreutzenberg, C. Crepaldi, S. Marchetto, L. Calò, A. Tiengo, S. Del Prato, and A. Avogaro Plasma Free Fatty Acids and Endothelium-Dependent Vasodilation: Effect of Chain-Length and Cyclooxygenase Inhibition J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 793 - 798. [Abstract] [Full Text] |
||||
![]() |
K. van der Zander, A. J.H.M Houben, A. A Kroon, and P. W de Leeuw Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide Cardiovasc Res, December 1, 1999; 44(3): 595 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vervoort, J. F. Wetzels, J. A. Lutterman, L. G. van Doorn, J. H. Berden, and P. Smits Elevated Skeletal Muscle Blood Flow in Noncomplicated Type 1 Diabetes Mellitus : Role of Nitric Oxide and Sympathetic Tone Hypertension, November 1, 1999; 34(5): 1080 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Davie and J. J. V. McMurray Effect of Angiotensin-(1-7) and Bradykinin in Patients With Heart Failure Treated With an ACE Inhibitor Hypertension, September 1, 1999; 34(3): 457 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Verhaar, R. M. F. Wever, J. J. P. Kastelein, D. van Loon, S. Milstien, H. A. Koomans, and T. J. Rabelink Effects of Oral Folic Acid Supplementation on Endothelial Function in Familial Hypercholesterolemia : A Randomized Placebo-Controlled Trial Circulation, July 27, 1999; 100(4): 335 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Davie, H. J. Dargie, and J. J. V. McMurray Role of Bradykinin in the Vasodilator Effects of Losartan and Enalapril in Patients With Heart Failure Circulation, July 20, 1999; 100(3): 268 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Henry, D. E. Newby, D. J. Webb, and C. O’Brien Peripheral Endothelial Dysfunction in Normal Pressure Glaucoma Invest. Ophthalmol. Vis. Sci., July 1, 1999; 40(8): 1710 - 1714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Verhaar, M. L.H. Honing, T. van Dam, M. Zwart, H. A. Koomans, J. J.P. Kastelein, and T. J. Rabelink Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids Cardiovasc Res, June 1, 1999; 42(3): 752 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Newby, R. A. Wright, C. Labinjoh, C. A. Ludlam, K. A. A. Fox, N. A. Boon, and D. J. Webb Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking : A Mechanism for Arterial Thrombosis and Myocardial Infarction Circulation, March 23, 1999; 99(11): 1411 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kelm, H. Preik-Steinhoff, M. Preik, and B. E. Strauer Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway Cardiovasc Res, March 1, 1999; 41(3): 765 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Cleland, J. R. Petrie, S. Ueda, H. L. Elliott, and J. M. C. Connell Insulin-Mediated Vasodilation and Glucose Uptake Are Functionally Linked in Humans Hypertension, January 1, 1999; 33(1): 554 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Stein, H. B. He, and A. J. J. Wood Basal and Stimulated Sympathetic Responses After Epinephrine : No Evidence of Augmented Responses Hypertension, December 1, 1998; 32(6): 1016 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pickkers, A. D. Hughes, F. G. M. Russel, T. Thien, and P. Smits Thiazide-Induced Vasodilation in Humans Is Mediated by Potassium Channel Activation Hypertension, December 1, 1998; 32(6): 1071 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
D E Newby, N E R Goodfield, A D Flapan, N A Boon, K A A Fox, and D J Webb Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II Heart, August 1, 1998; 80(2): 134 - 140. [Abstract] [Full Text] |
||||
![]() |
S. John, M. Schlaich, M. Langenfeld, H. Weihprecht, G. Schmitz, G. Weidinger, and R. E. Schmieder Increased Bioavailability of Nitric Oxide After Lipid-Lowering Therapy in Hypercholesterolemic Patients : A Randomized, Placebo-Controlled, Double-blind Study Circulation, July 21, 1998; 98(3): 211 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ueda, J. R. Petrie, S. J. Cleland, H. L. Elliott, and J. M. C. Connell The Vasodilating Effect of Insulin Is Dependent on Local Glucose Uptake: A Double Blind, Placebo-Controlled Study J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2126 - 2131. [Abstract] [Full Text] |
||||
![]() |
J. P Noon, B. R Walker, M. F Hand, and D. J Webb Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin Cardiovasc Res, May 1, 1998; 38(2): 480 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E Newby, R. A Wright, P. Dawson, C. A Ludlam, N. A Boon, K. A.A Fox, and D. J Webb The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man Cardiovasc Res, May 1, 1998; 38(2): 485 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Newby, R. Jalan, S. Masumori, P. C. Hayes, N. A. Boon, and D. J. Webb Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems Cardiovasc Res, April 1, 1998; 38(1): 221 - 228. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |